Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Effect of Gardening on Brain Activity
Effect of Gardening on Brain Activity
Status: Enrolling
Updated:  12/31/1969
McKnight Brain Institute
1049
mi
from
Gainesville, FL
Effect of Gardening on Brain Activity
Effect of Gardening on Brain Activity
Status: Enrolling
Updated: 12/31/1969
McKnight Brain Institute
1049
mi
from
Gainesville, FL
Click here to add this to my saved trials
Effect of Gardening on Brain Activity
Effect of Gardening on Brain Activity
Status: Enrolling
Updated:  12/31/1969
Wilmot Greenhouse
1049
mi
from
Gainesville, FL
Effect of Gardening on Brain Activity
Effect of Gardening on Brain Activity
Status: Enrolling
Updated: 12/31/1969
Wilmot Greenhouse
1049
mi
from
Gainesville, FL
Click here to add this to my saved trials
Treatment for Teens With Alcohol Abuse and Depression
Treatment for Teens With Alcohol Abuse and Depression
Status: Enrolling
Updated:  12/31/1969
University of Connecticut Health Center
1350
mi
from
Farmington, CT
Treatment for Teens With Alcohol Abuse and Depression
Treatment for Teens With Alcohol Abuse and Depression
Status: Enrolling
Updated: 12/31/1969
University of Connecticut Health Center
1350
mi
from
Farmington, CT
Click here to add this to my saved trials
Treatment for Teens With Alcohol Abuse and Depression
Treatment for Teens With Alcohol Abuse and Depression
Status: Enrolling
Updated:  12/31/1969
Duke Child and Family Study Center
1047
mi
from
Durham, NC
Treatment for Teens With Alcohol Abuse and Depression
Treatment for Teens With Alcohol Abuse and Depression
Status: Enrolling
Updated: 12/31/1969
Duke Child and Family Study Center
1047
mi
from
Durham, NC
Click here to add this to my saved trials
Games to Overcome Late Life Depression
Games to Overcome Late Life Depression
Status: Enrolling
Updated:  12/31/1969
University of Washington Department of Psychiatry and Behavioral Sciences
1410
mi
from
Seattle, WA
Games to Overcome Late Life Depression
Games to Overcome Late Life Depression
Status: Enrolling
Updated: 12/31/1969
University of Washington Department of Psychiatry and Behavioral Sciences
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Bupropion for Depression in ESRD Patients on Hemodialysis
Bupropion for Depression in ESRD Patients on Hemodialysis
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences
370
mi
from
Little Rock, AR
Bupropion for Depression in ESRD Patients on Hemodialysis
Bupropion for Depression in ESRD Patients on Hemodialysis
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
370
mi
from
Little Rock, AR
Click here to add this to my saved trials
Improving Adolescent Health Outcomes Through Preventive Care Transformation
Improving Adolescent Health Outcomes Through Preventive Care Transformation
Status: Enrolling
Updated:  12/31/1969
Eskenazi Medical Group
643
mi
from
Indianapolis, IN
Improving Adolescent Health Outcomes Through Preventive Care Transformation
Improving Adolescent Health Outcomes Through Preventive Care Transformation
Status: Enrolling
Updated: 12/31/1969
Eskenazi Medical Group
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Research Aimed at Improving Both Mood and Weight
RCT on Co-management of Obesity, Depression, and Elevated CVD Risk in Primary Care-- Engaging Self-regulation Targets to Understand the Mechanisms of Behavior Change and Improve Mood and Weight Outcomes
Status: Enrolling
Updated:  12/31/1969
Palo Alto Medical Foundation
1328
mi
from
Palo Alto, CA
Research Aimed at Improving Both Mood and Weight
RCT on Co-management of Obesity, Depression, and Elevated CVD Risk in Primary Care-- Engaging Self-regulation Targets to Understand the Mechanisms of Behavior Change and Improve Mood and Weight Outcomes
Status: Enrolling
Updated: 12/31/1969
Palo Alto Medical Foundation
1328
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Research Aimed at Improving Both Mood and Weight
RCT on Co-management of Obesity, Depression, and Elevated CVD Risk in Primary Care-- Engaging Self-regulation Targets to Understand the Mechanisms of Behavior Change and Improve Mood and Weight Outcomes
Status: Enrolling
Updated:  12/31/1969
Stanford University
1329
mi
from
Stanford, CA
Research Aimed at Improving Both Mood and Weight
RCT on Co-management of Obesity, Depression, and Elevated CVD Risk in Primary Care-- Engaging Self-regulation Targets to Understand the Mechanisms of Behavior Change and Improve Mood and Weight Outcomes
Status: Enrolling
Updated: 12/31/1969
Stanford University
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Perimenopausal Effects of Estradiol on Reward Responsiveness
Effects of Estradiol on Neural Reward System and Depression in the Perimenopause
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
1043
mi
from
Chapel Hill, NC
Perimenopausal Effects of Estradiol on Reward Responsiveness
Effects of Estradiol on Neural Reward System and Depression in the Perimenopause
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
1043
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
rTMS for PTSD Comorbid With Major Depressive Disorder
5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Butler Hospital
1424
mi
from
Providence, RI
rTMS for PTSD Comorbid With Major Depressive Disorder
5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
1424
mi
from
Providence, RI
Click here to add this to my saved trials
rTMS for PTSD Comorbid With Major Depressive Disorder
5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Providence VA Medical Center
1424
mi
from
Providence, RI
rTMS for PTSD Comorbid With Major Depressive Disorder
5Hz Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Comorbid With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Providence VA Medical Center
1424
mi
from
Providence, RI
Click here to add this to my saved trials
Improving Mood in Veterans in Primary Care
RCT of Behavioral Activation for Depression and Suicidality in Primary Care
Status: Enrolling
Updated:  12/31/1969
VA Western New York Healthcare System, Buffalo, NY
1060
mi
from
Buffalo, NY
Improving Mood in Veterans in Primary Care
RCT of Behavioral Activation for Depression and Suicidality in Primary Care
Status: Enrolling
Updated: 12/31/1969
VA Western New York Healthcare System, Buffalo, NY
1060
mi
from
Buffalo, NY
Click here to add this to my saved trials
Improving Mood in Veterans in Primary Care
RCT of Behavioral Activation for Depression and Suicidality in Primary Care
Status: Enrolling
Updated:  12/31/1969
Canandaigua VA Medical Center, Canandaigua, NY
1135
mi
from
Canandaigua, NY
Improving Mood in Veterans in Primary Care
RCT of Behavioral Activation for Depression and Suicidality in Primary Care
Status: Enrolling
Updated: 12/31/1969
Canandaigua VA Medical Center, Canandaigua, NY
1135
mi
from
Canandaigua, NY
Click here to add this to my saved trials
Improving Mood in Veterans in Primary Care
RCT of Behavioral Activation for Depression and Suicidality in Primary Care
Status: Enrolling
Updated:  12/31/1969
Syracuse VA Medical Center, Syracuse, NY
1194
mi
from
Syracuse, NY
Improving Mood in Veterans in Primary Care
RCT of Behavioral Activation for Depression and Suicidality in Primary Care
Status: Enrolling
Updated: 12/31/1969
Syracuse VA Medical Center, Syracuse, NY
1194
mi
from
Syracuse, NY
Click here to add this to my saved trials
A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression (Abbreviation Assurex AMOD)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
515
mi
from
Rochester, MN
A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression (Abbreviation Assurex AMOD)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
515
mi
from
Rochester, MN
Click here to add this to my saved trials
A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression (Abbreviation Assurex AMOD)
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression (Abbreviation Assurex AMOD)
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
683
mi
from
Birmingham, AL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
683
mi
from
Birmingham, AL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes' Investigational Study Site
830
mi
from
Tucson, AZ
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes' Investigational Study Site
830
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
372
mi
from
Little Rock, AR
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1176
mi
from
Beverly Hills, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1176
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1175
mi
from
Carson, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1175
mi
from
Carson, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1162
mi
from
Garden Grove, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1162
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1167
mi
from
Glendale, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1167
mi
from
Glendale, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1164
mi
from
Los Alamitos, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1164
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1168
mi
from
Los Angeles, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1140
mi
from
National City, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1140
mi
from
National City, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1331
mi
from
Oakland, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1331
mi
from
Oakland, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1138
mi
from
Oceanside, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1138
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1154
mi
from
Orange, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1154
mi
from
Orange, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1161
mi
from
Pico Rivera, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1161
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1110
mi
from
Redlands, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1110
mi
from
Redlands, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1160
mi
from
San Gabriel, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1160
mi
from
San Gabriel, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1177
mi
from
Sherman Oaks, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1177
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1122
mi
from
Temecula, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1122
mi
from
Temecula, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1176
mi
from
Torrance, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1176
mi
from
Torrance, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1135
mi
from
Upland, CA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1135
mi
from
Upland, CA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
386
mi
from
Colorado Springs, CO
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
386
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
409
mi
from
Denver, CO
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
409
mi
from
Denver, CO
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1357
mi
from
Hartford, CT
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1357
mi
from
Hartford, CT
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1389
mi
from
Norwich, CT
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1389
mi
from
Norwich, CT
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1142
mi
from
Bradenton, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1142
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1294
mi
from
Coral Springs, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1294
mi
from
Coral Springs, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1204
mi
from
Fort Myers, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1204
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1045
mi
from
Gainesville, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1045
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1313
mi
from
Hallandale Beach, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1313
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1309
mi
from
Hialeah, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1309
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1065
mi
from
Jacksonville, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1065
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
1065
mi
from
Jacksonville, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
1065
mi
from
Jacksonville, FL
Click here to add this to my saved trials